Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
would they have to restart the dose or will they still proceed getting their 2nd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 01-JAN-2021). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: would they have to restart the dose or will they still proceed getting their 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 09-APR-2025 The health care professional reported that a patient had her 1st (Shingrix) dose in 2021, would they have to restart the dose or will they still proceed getting their 2nd dose. At the beginning of the call, HCP mentioned that this was about Shingrix only mentioned 2021 as the vaccination date for 1st dose, but she did not have the specific date (reporter set this as 01-01-2021 due to the system did not allow only the year). Health care professional mentioned that the patient is not immunocompromised. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.